J. Robert Coleman
CEO,
Hervolution, ApS
Denmark
Dr. Coleman is a distinguished scientist, entrepreneur, biotech CEO, and company builder who brings a wealth of experience in driving ground-breaking platform technologies from initial innovation to Phase 3 clinical trials and beyond. Coleman’s specific track record is in early- and late-stage development of viral-based vaccines and therapeutics, securing over $498 million in public and private financing. Coleman has a keen ability to maximize shareholder value through creative and thoughtful management of multi-asset / multi-disciplary pipelines.
)
){kind=logo}
)
){kind=logo}
){kind=logo}